Recent studies have raised serious concerns about a potential link between Ozempic (semaglutide) and a rare eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION). NAION is characterized by sudden, painless vision loss due to reduced blood flow to the optic nerve.